Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

48North Cannabis Corp. V.NRTH


Primary Symbol: NCNNF

Healthcare Drug Manufacturers - Specialty & Generic
48North Cannabis Corp is a vertically integrated cannabis company. It is focused on the health and wellness market through cultivation and extraction, as well as the creation of authentic brands for consumer-friendly products. Its products are categorized into Bath, Intimacy, Flower, Pre-roll, topical, vapes, concentrates, and accessories. It has two geographical segments: Canada, which is the key revenue driver; and the United States.


OTCPK:NCNNF - Post by User

48North Cannabis Corp.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(14)
•••
Post by cookn59on Sep 23, 2020 7:43pm
150 Views
Post# 31608945

Good interview

Good interview https://l.facebook.com/l.php?u=https%3A%2F%2Fwww.thinkingoutsidethebud.com%2Fpodcast%2F179-charles-vennat%3Ffbclid%3DIwAR3OoSGD_Uzszrf4wI35tsULY5NZoXfSxZmU0JLvlBuVh8T52SMpfOrc250&h=AT1GcLDuUIB03I6n9lBXSxusIOqhgthSr-YI0p6H3LdBD4zo9KlQUkRB1rFPe_16HxhFDOA7toW575vGZVNSQ1KzQKMVe6_4WrGayIbw74jEtjWzsuPzEXr8bPdoLeRjGk4rNA&__tn__=-UK-R&c[0]=AT2pBMpy3VWVjFjCmBgsPwQ3mIFdlG1B6tYDoZ3gFFwc2hti04q0QnxSxOpUsirU8zs4TJPcqni52IM-g3upOz4ciRq8UtyMhjVCf6LhOXEGVQ4czMwuI22-1Px9Um1bt2BmpPHdU-U059aGxnH2iO2eRaXmUh6vhj7IPQio-3zpF-g0m2VgOG5wD48Sugt1BOXaAhd4Zj7H48C1
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities